Skip to the main content.

1 min read

Alcami Announces Chief Financial Officer Transition


Wilmington, North Carolina – March 9, 2023 – Alcami Corporation ("Alcami"), a leading contract development and manufacturing organization (CDMO), today announced the promotion of Ken Morgan to Chief Financial Officer.  

Ken brings over 25 years of experience in the pharmaceutical industry with considerable experience in finance, mergers, acquisitions, and information system implementations. Ken joined AAIPharma (now Alcami) in 1997 and has served in numerous financial leadership roles throughout his long-standing tenure with the company. Before rejoining Alcami, he was the Vice President and Controller of TriPharm Services, a parenteral contract manufacturing organization acquired by Alcami. Ken has a BS in Accountancy from the University of North Carolina at Wilmington. 

After an exceptional 40-year career spanning all facets of the pharmaceutical industry, Alcami Chief Financial Officer Eric Evans has announced his intention to retire in 2023. 

“Eric’s track record as CFO of multiple high-growth organizations is truly impressive, and we thank him for his leadership and contribution at Alcami,” commented Patrick Walsh, Chairman and Chief Executive Officer at Alcami Corporation. “We also congratulate Ken on his promotion, knowing his leadership skills and 24 years of tenure at Alcami will serve him well in his new role."